231 related articles for article (PubMed ID: 17667943)
1. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
[TBL] [Abstract][Full Text] [Related]
4. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
[TBL] [Abstract][Full Text] [Related]
5. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23.
Katoh M; Katoh M
Int J Oncol; 2003 Oct; 23(4):1219-24. PubMed ID: 12964007
[TBL] [Abstract][Full Text] [Related]
7. Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastoma.
Henrich KO; Claas A; Praml C; Benner A; Mollenhauer J; Poustka A; Schwab M; Westermann F
Eur J Cancer; 2007 Feb; 43(3):607-16. PubMed ID: 17222547
[TBL] [Abstract][Full Text] [Related]
8. An integrated 5-Mb physical, genetic, and radiation hybrid map of a 1p36.1 region implicated in neuroblastoma pathogenesis.
Spieker N; Beitsma M; van Sluis P; Roobeek I; den Dunnen JT; Speleman F; Caron H; Versteeg R
Genes Chromosomes Cancer; 2000 Feb; 27(2):143-52. PubMed ID: 10612802
[TBL] [Abstract][Full Text] [Related]
9. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
10. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells.
Henrich KO; Bauer T; Schulte J; Ehemann V; Deubzer H; Gogolin S; Muth D; Fischer M; Benner A; König R; Schwab M; Westermann F
Cancer Res; 2011 Apr; 71(8):3142-51. PubMed ID: 21385898
[TBL] [Abstract][Full Text] [Related]
11. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
Genes Chromosomes Cancer; 2001 Jul; 31(3):228-39. PubMed ID: 11391793
[TBL] [Abstract][Full Text] [Related]
12. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
Fransson S; Martinsson T; Ejeskär K
Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.
Mathysen D; Van Roy N; Van Hul W; Laureys G; Ambros P; Speleman F; Wuyts W
Eur J Cancer; 2004 May; 40(8):1255-61. PubMed ID: 15110891
[TBL] [Abstract][Full Text] [Related]
15. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
Spieker N; Beitsma M; Van Sluis P; Chan A; Caron H; Versteeg R
Genes Chromosomes Cancer; 2001 Jun; 31(2):172-81. PubMed ID: 11319804
[TBL] [Abstract][Full Text] [Related]
16. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
[TBL] [Abstract][Full Text] [Related]
18. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
19. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP.
Amler LC; Bauer A; Corvi R; Dihlmann S; Praml C; Cavenee WK; Schwab M; Hampton GM
Genomics; 2000 Mar; 64(2):195-202. PubMed ID: 10729226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]